Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CD4 Deficiency”

305 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 305 results

Early research (Phase 1)Study completedNCT00000984
What this trial is testing

A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 (rCD4) in Infants and Children Infected With or at Risk for HIV Infection

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 40
Early research (Phase 1)Study completedNCT00000642
What this trial is testing

A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 Immunoglobulin G (rCD4-IgG) in HIV-1 Seropositive Women During the Last Trimester of Pregnancy and Their Newborns

Who this might be right for
HIV InfectionsPregnancy
National Institute of Allergy and Infectious Diseases (NIAID) 30
Testing effectiveness (Phase 2)Study completedNCT00289952
What this trial is testing

Valproic Acid and Its Effects on HIV Latent Reservoirs

Who this might be right for
HIV Infections
Jean-Pierre Routy 50
Large-scale testing (Phase 3)Study completedNCT00025909
What this trial is testing

Intermittent vs. Continuous HAART to Treat Chronic HIV Infection

Who this might be right for
HIV Infection
National Institute of Allergy and Infectious Diseases (NIAID) 90
Testing effectiveness (Phase 2)Study completedNCT00000838
What this trial is testing

Antiviral Activity of and Resistance to Lamivudine in Combination With Zidovudine, Stavudine, or Didanosine

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 256
Testing effectiveness (Phase 2)Temporarily pausedNCT03312244
What this trial is testing

Pyridostigmine as Immunomodulator in People Living With HIV

Who this might be right for
HIV-1-infectionCD4+ T LymphocytopeniaImmune Deficiency+1 more
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 60
Not applicableStudy completedNCT02934022
What this trial is testing

Adding Maraviroc to the HAART Regimen of Well Controlled HIV-infected Patients

Who this might be right for
HIV Infection
Southern California Institute for Research and Education 25
Early research (Phase 1)Study completedNCT00002129
What this trial is testing

A Phase I Study of Three Doses of OPC-8212 (Vesnarinone) in HIV-Infected Persons With CD4+ Cell Number > 300 Cells/mm3

Who this might be right for
HIV Infections
Otsuka America Pharmaceutical 36
Testing effectiveness (Phase 2)Study completedNCT00000872
What this trial is testing

Treatment With Combinations of Several Antiviral Drugs in Infants and Young Children With HIV Infection

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 55
Not applicableStudy completedNCT00002172
What this trial is testing

An Expanded Access Open-Label, Compassionate Use Protocol of Remune in HIV-1-Infected Adults With CD4 Count Less Than 300 Cells/Ml

Who this might be right for
HIV Infections
The Immune Response Corporation
Not applicableStudy completedNCT00002161
What this trial is testing

A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Adefovir Dipivoxil When Added to Standard Antiretroviral Therapy for the Treatment of HIV-Infected Patients With CD4 Cell Counts >= 200/mm3

Who this might be right for
HIV Infections
Gilead Sciences 400
Testing effectiveness (Phase 2)Study completedNCT00113282
What this trial is testing

Efficacy of Adding Interleukin-2 to an Optimized Antiretroviral Regimen in HIV Patients in Therapeutic Failure (ANRS123)

Who this might be right for
HIV Infections
French National Agency for Research on AIDS and Viral Hepatitis 57
Not applicableStudy completedNCT03158987
What this trial is testing

Regional Differences in Human Immunodeficiency Virus (HIV) Testing

Who this might be right for
HIV SeropositivityCD4+ T Lymphocytopenia
Jena University Hospital 999
Not applicableStudy completedNCT00017771
What this trial is testing

Nerve Damage in Patients With HIV Infection Who Have Been Treated With Anti-HIV Drugs

Who this might be right for
HIV InfectionsPeripheral Nervous System Disease
National Institute of Allergy and Infectious Diseases (NIAID) 100
Testing effectiveness (Phase 2)Study completedNCT00189930
What this trial is testing

An Evaluation of Immunogenicity and Safety of Two Doses of MVA-nef vs. MVA-BN in HIV-1 Infected Patients

Who this might be right for
HIV Infection
Bavarian Nordic 77
Testing effectiveness (Phase 2)Study completedNCT00001063
What this trial is testing

The Effectiveness of Three Drug Combinations in HIV-Infected Patients Who Have Taken Zidovudine for More Than 12 Weeks

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 200
Not applicableStudy completedNCT00000907
What this trial is testing

Examine the Effects of Stopping Preventive Therapy for Disseminated Mycobacterium Avium Complex (DMAC) in HIV-Positive Patients

Who this might be right for
Mycobacterium Avium-Intracellulare InfectionHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 50
Testing effectiveness (Phase 2)Study completedNCT03666871
What this trial is testing

CCR5-modified CD4+ T Cells for HIV Infection

Who this might be right for
HIV Infections
University of Cincinnati 30
Early research (Phase 1)Study completedNCT00000663
What this trial is testing

A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 Immunoglobulin G (rCD4-IgG) in Infants and Children With Documented HIV-1 Infection

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 18
Not applicableStudy completedNCT00000859
What this trial is testing

Trial of the Efficacy and Safety of a Strategy of Starting With Nelfinavir Versus Ritonavir Added to Background Antiretroviral (AR) Nucleoside Therapy in HIV-Infected Individuals With CD4+ Cell Counts Less Than or Equal to 200/mm3

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 1,300
Load More Results